Sugi Predict

Sugi Predict / Compounds / SCHEMBL16068174

SCHEMBL16068174

SCHEMBL16068174

[N-]=[N+]=NCCCCN1C(=O)c2ccccc2C1=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 1/20 0.53
▸ L3MBTL1 Q9Y468 1/20 0.53
▸ ALDH1A1 P00352 1/20 0.52
▸ MAPT P10636 1/20 0.49
▸ RAB9A P51151 1/20 0.49
▸ SMN1; SMN2 Q16637 1/20 0.49
▸ HDAC8 Q9BY41 3/20 0.48
▸ HDAC3 O15379 2/20 0.48
▸ HDAC4 P56524 2/20 0.48
▸ HDAC1 Q13547 2/20 0.48
▸ HDAC7 Q8WUI4 2/20 0.48
▸ HDAC2 Q92769 2/20 0.48
▸ HDAC10 Q969S8 2/20 0.48
▸ HDAC11 Q96DB2 2/20 0.48
▸ HDAC6 Q9UBN7 2/20 0.48
▸ HDAC9 Q9UKV0 2/20 0.48
▸ HDAC5 Q9UQL6 2/20 0.48
▸ CYP1A2 P05177 1/20 0.47
▸ CYP2D6 P10635 1/20 0.47
▸ CYP2C19 P33261 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30041074 1.00 TDP1 (0.53) TDP1L3MBTL1ALDH1A1MAPTRAB9A
SCHEMBL13884659 0.98 TDP1 (0.55) TDP1L3MBTL1ALDH1A1HDAC8HDAC3
SCHEMBL20595306 0.98 TDP1 (0.55) TDP1L3MBTL1ALDH1A1HDAC8HDAC3
SCHEMBL17872139 0.98 TDP1 (0.55) TDP1L3MBTL1ALDH1A1HDAC8HDAC3
SCHEMBL29707271 0.95 ALDH1A1 (0.54) TDP1L3MBTL1ALDH1A1MAPTRAB9A
SCHEMBL13509920 0.95 ALDH1A1 (0.54) TDP1L3MBTL1ALDH1A1MAPTRAB9A
SCHEMBL13754582 0.88 GLS (0.52) TDP1L3MBTL1ALDH1A1MAPTRAB9A
SCHEMBL30999497 0.88 GLS (0.52) TDP1L3MBTL1ALDH1A1MAPTRAB9A
SCHEMBL6790333 0.82 TDP1 (0.71) TDP1L3MBTL1MAPTRAB9ASMN1; SMN2
SCHEMBL14345593 0.80 HDAC8 (0.60) TDP1L3MBTL1ALDH1A1HDAC8HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4747260-A1 MACROCYCLES FOR THE TREATMENT OF AUTOIMMUNE DISEASE F. Hoffmann-La Roche AG (CH) 2026-05-27 — — EP disclosed
WO-2025021666-A1 MACROCYCLES FOR THE TREATMENT OF AUTOIMMUNE DISEASE F. HOFFMANN-LA ROCHE AG (CH) 2025-01-30 — — WO disclosed
CN-112334454-B Environment-friendly olefin hydration reaction 佐治亚州立大学研究基金会公司 2024-04-30 — — CN disclosed
US-11708320-B2 Environmentally-friendly hydroazidation of olefins GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2023-07-25 — — US disclosed
US-11708320-B2 Environmentally-friendly hydroazidation of olefins GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2023-07-25 — — US disclosed
US-11708320-B2 Environmentally-friendly hydroazidation of olefins GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2023-07-25 — — US disclosed
US-20210284601-A1 ENVIRONMENTALLY-FRIENDLY HYDROAZIDATION OF OLEFINS GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. 2021-09-16 — — US disclosed
US-20210284601-A1 ENVIRONMENTALLY-FRIENDLY HYDROAZIDATION OF OLEFINS GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. 2021-09-16 — — US disclosed
EP-3784660-A1 ENVIRONMENTALLY-FRIENDLY HYDROAZIDATION OF OLEFINS Georgia State University Research Foundation, Inc. (US) 2021-03-03 — — EP disclosed
CN-112334454-A Environmentally friendly olefin hydration reactions 佐治亚州立大学研究基金会公司 2021-02-05 — — CN disclosed
US-20200040024-A1 CONVERGENT PROCESSES FOR PREPARING MACROLIDE ANTIBACTERIAL AGENTS Têtard, Inc. (US) 2020-02-06 — — US disclosed
US-20190023731-A1 CONVERGENT PROCESSES FOR PREPARING MACROLIDE ANTIBACTERIAL AGENTS TETARD, INC. 2019-01-24 — — US disclosed
US-9751908-B2 Convergent processes for preparing macrolide antibacterial agents CEMPRA PHARMACEUTICALS, INC. (US) 2017-09-05 — — US disclosed
US-9751908-B2 Convergent processes for preparing macrolide antibacterial agents CEMPRA PHARMACEUTICALS, INC. (US) 2017-09-05 — — US disclosed
EP-3190122-A1 A NOVEL SYNTHETIC PATHWAY TOWARDS SOLITHROMYCIN AND PURIFICATION THEREOF LEK Pharmaceuticals d.d. (SI) 2017-07-12 — — EP disclosed
US-20160046660-A1 CONVERGENT PROCESSES FOR PREPARING MACROLIDE ANTIBACTERIAL AGENTS TETARD, INC. 2016-02-18 — — US disclosed
US-20160046660-A1 CONVERGENT PROCESSES FOR PREPARING MACROLIDE ANTIBACTERIAL AGENTS TETARD, INC. 2016-02-18 — — US disclosed
WO-2014145210-A1 CONVERGENT PROCESSES FOR PREPARING MACROLIDE ANTIBACTERIAL AGENTS CEMPRA PHARMACEUTICALS, INC. (US) 2014-09-18 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160046660-A1 CONVERGENT PROCESSES FOR PREPARING MACROLIDE ANTIBACTERIAL AGENTS COASY, TKT, CYP51A1 TDP1 3821/4885L3MBTL1 2836/4885ALDH1A1 2925/4885
US-20190023731-A1 CONVERGENT PROCESSES FOR PREPARING MACROLIDE ANTIBACTERIAL AGENTS COASY, TKT, CYP51A1 TDP1 3821/4885L3MBTL1 2836/4885ALDH1A1 2925/4885
US-20200040024-A1 CONVERGENT PROCESSES FOR PREPARING MACROLIDE ANTIBACTERIAL AGENTS COASY, TKT, CYP51A1 TDP1 3821/4885L3MBTL1 2836/4885ALDH1A1 2925/4885
US-11708320-B2 Environmentally-friendly hydroazidation of olefins HAO2, AHR, HMOX1 TDP1 2142/4885L3MBTL1 1886/4885ALDH1A1 116/4885
US-20210284601-A1 ENVIRONMENTALLY-FRIENDLY HYDROAZIDATION OF OLEFINS HAO2, AHR, HMOX1 TDP1 2142/4885L3MBTL1 1886/4885ALDH1A1 116/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback